Evidence map›Paper›PMID 36368881›Full record

ArticleHeart (British Cardiac Society)2023

Prognostic implications of atrial fibrillation in adults with Ebstein anomaly.

Irene Martin de Miguel, Malini Madhavan, William R Miranda, Heidi M Connolly, Alexander C Egbe

Open access · greenAbstract read
In one paragraph

Article in Heart (British Cardiac Society), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Morbidity Burden in Patients With Ebstein Anomaly: The Natural History.Journal of the American Heart Association · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Irene Martin de MiguelDepartment of Cardiovascular Medicine, Mayo Clinic Minnesota, Rochester, Minnesota, USA.ORCID 0000-0002-0889-1608
Malini MadhavanDepartment of Cardiovascular Medicine, Mayo Clinic Minnesota, Rochester, Minnesota, USA.ORCID 0000-0002-2831-4568
William R MirandaDepartment of Cardiovascular Medicine, Mayo Clinic Minnesota, Rochester, Minnesota, USA.ORCID 0000-0001-8864-8474
Heidi M ConnollyDepartment of Cardiovascular Medicine, Mayo Clinic Minnesota, Rochester, Minnesota, USA.
Alexander C EgbeDepartment of Cardiovascular Medicine, Mayo Clinic Minnesota, Rochester, Minnesota, USA egbe.alexander@mayo.edu.
Mayo Clinic · US

Funding

Mechanisms of Clinical and Hemodynamic Response to Pulmonary Vasodilator Therapy in Fontan physiologyR01HL160761 · NHLBI · MAYO CLINIC ROCHESTER · PI Alexander Egbe · 2022 to 2026
$3.1M
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of FallotR01HL158517 · NHLBI · MAYO CLINIC ROCHESTER · PI EGBE, ALEXANDER · 2021 to 2025
$2.9M
Ventricular and Pulmonary Vascular Reserve after the Fontan OperationK23HL141448 · NHLBI · MAYO CLINIC ROCHESTER · PI EGBE, ALEXANDER · 2018 to 2021
$693k
NHLBI NIH HHS K23 HL141448NHLBI NIH HHS R01 HL158517NHLBI NIH HHS R01 HL160761
6 · The paper itself

Abstract

objectiveSupraventricular arrhythmias are common in adults with Ebstein anomaly (EA). However, there are limited data about prognostic implications of atrial fibrillation (AF) in this population. Accordingly, our aim was to assess the clinical profile and burden of AF in adults with EA, and the relationship between AF and outcomes. METHODS AND

resultsSix hundred eighty-two consecutive adults with a median age of 36 (24-49) years from Mayo Clinic, Minnesota, USA, between 2003 and 2020 were included. Sustained episodes of AF, clinical, echocardiographic, rhythm and surgical data were collected. Prevalence of AF at baseline was 18% (126 patients); the first episode occurred at a mean age of 43±17 years. Patients with AF were older, were more likely men, and had hypertension, renal dysfunction, cardiac devices, and more advanced right-sided and left-sided remodelling. During a median follow-up of 156 (81-240) months, 62 patients (11%) developed incident AF. At the last encounter, prevalence of AF was 28% (188 patients); of those, 63 (34%) had recurrent AF. Hospitalisation for heart failure (HF) occurred in 51 patients (7%). AF (HR 2.32, 95% CI 1.18 to 4.47; p=0.01) was independently associated with hospitalisation for HF. All-cause death occurred in 53 patients (8%); it was more frequent in those with AF in the univariable analysis, although it did not remain significant in the multivariable analysis.

conclusionsAF in EA develops at relatively young ages with one-third of the cohort exhibiting a recurrent pattern. Patients with AF had a higher prevalence of comorbidities and worse right-sided and left-sided cardiac remodelling. AF was independently associated with HF hospitalisation.

Indexed as

Atrial FibrillationEbstein AnomalyHeart FailureAdultHeartHumansMaleMiddle AgedPrognosisRetrospective StudiesAtrial FibrillationEchocardiographyHeart Defects, CongenitalHeart failureTricuspid Valve Insufficiency

Identifiers

PMID36368881
PMCPMC9975025
OpenAlexW4308834578

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.